White matter fractional anisotropy over two time points in early onset schizophrenia and adolescent cannabis use disorder: A naturalistic diffusion tensor imaging study

Psychiatry Research - Neuroimaging

Volumn 232, Issue 1, 2015, Pages 34-41

  Epstein, Katherine A ^a   Kumra, Sanjiv ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adolescent; Cannabis; Early onset schizophrenia (EOS); Fractional anisotropy (FA); Left inferior fronto occipital fasciculus (IFOF); Left inferior longitudinal fasciculus (ILF)

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; CHILD; CINGULUM BUNDLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; DOSE RESPONSE; EXPLORATORY RESEARCH; FOLLOW UP; FRACTIONAL ANISOTROPY; HELP SEEKING BEHAVIOR; HUMAN; INFERIOR FRONTOOCCIPITAL FASCICULUS; INFERIOR LONGITUDINAL FASCICULUS; LONGITUDINAL STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SUPERIOR LONGITUDINAL FASCICULUS; UNCINATE FASCICULUS; WHITE MATTER; ANISOTROPY; BRAIN; CANNABIS SMOKING; FEMALE; MALE; NERVE CELL NETWORK; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ANISOTROPY; BRAIN; CHILD; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; NERVE NET; PILOT PROJECTS; SCHIZOPHRENIA; WHITE MATTER; YOUNG ADULT;

EID: 84927909232     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2014.10.010     Document Type: Article

References (55)

1. Anderson S.L., Vande Griend J.P. Quetiapine for insomnia: a review of the literature. American Journal of Health-System Pharmacy 2014, 71:394-402.
2. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biological Psychiatry 2010, 67:255-262.
3. Arnone D., Barrick T.R., Chengappa S., Mackay C.E., Clark C.A., Abou-Saleh M.T. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. NeuroImage 2008, 41:1067-1074.
4. Ashtari M., Cervellione K., Cottone J., Ardekani B.A., Sevy S., Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. Journal of Psychiatric Research 2009, 43:189-204.
5. Ashtari M., Cottone J., Ardekani B.A., Cervellione K., Szeszko P.R., Wu J., Chen S., Kumra S. Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography. Archives of General Psychiatry 2007, 64:1270-1280.
6. Baker S.T., Yucel M., Fornito A., Allen N.B., Lubman D.I. A systematic review of diffusion weighted MRI studies of white matter microstructure in adolescent substance users. Neuroscience and Biobehavioral Reviews 2013, 37:1713-1723.
7. Bava S., Frank L.R., McQueeny T., Schweinsburg B.C., Schweinsburg A.D., Tapert S.F. Altered white matter microstructure in adolescent substance users. Psychiatry Research: Neuroimaging 2009, 173:228-237.
8. Bava S., Jacobus J., Mahmood O., Yang T.T., Tapert S.F. Neurocognitive correlates of white matter quality in adolescent substance users. Brain and Cognition 2010, 72:347-354.
9. Bava S., Jacobus J., Thayer R.E., Tapert S.F. Longitudinal changes in white matter integrity among adolescent substance users. Alcoholism, Clinical and Experimental Research 2013, 37(Suppl 1):E181-E189.
10. Behrens T.E., Berg H.J., Jbabdi S., Rushworth M.F., Woolrich M.W. Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?. NeuroImage 2007, 34:144-155.
11. Bouaboula M., Bourrie B., Rinaldi-Carmona M., Shire D., Le Fur G., Casellas P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. Journal of Biological Chemistry 1995, 270:13973-13980.
12. Bourgeois J.P., Rakic P. Changes of synaptic density in the primary visual cortex of the macaque monkey from fetal to adult stage. Journal of Neuroscience 1993, 13:2801-2820.
13. Casadio P., Fernandes C., Murray R.M., Di Forti M. Cannabis use in young people: the risk for schizophrenia. Neuroscience and Biobehavioral Reviews 2011, 35:1779-1787.
14. Casey B.J., Oliveri M.E., Insel T. A neurodevelopmental perspective on the research domain criteria (RDC) framework. Biological Psychiatry 2014, 76:350-353.
15. Ciccarelli O., Behrens T.E., Altmann D.R., Orrell R.W., Howard R.S., Johansen-Berg H., Miller D.H., Matthews P.M., Thompson A.J. Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain 2006, 129:1859-1871.
16. Delisi L.E., Bertisch H.C., Szulc K.U., Majcher M., Brown K., Bappal A., Ardekani B.A. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduction Journal 2006, 3:17.
17. Dennis M.L., Funk R., Godley S.H., Godley M.D., Waldron H. Cross-validation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment. Addiction 2004, 99(Suppl 2):S120-S128.
18. Ellison-Wright I., Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophrenia Research 2009, 108:3-10.
19. Epstein K.A., Cullen K.R., Mueller B.A., Robinson P., Lee S., Kumra S. White matter abnormalities and cognitive impairment in early-onset schizophrenia-spectrum disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2014, 53(362-372):e361-e362.
20. Giorgio A., Watkins K.E., Chadwick M., James S., Winmill L., Douaud G., De Stefano N., Matthews P.M., Smith S.M., Johansen-Berg H., James A.C. Longitudinal changes in grey and white matter during adolescence. NeuroImage 2010, 49:94-103.
21. Gruber S.A., Yurgelun-Todd D.A. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Research: Cognitive Brain Research 2005, 23:107-118.
22. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., Busa E., Pacheco J., Albert M., Killiany R., Maguire P., Rosas D., Makris N., Dale A., Dickerson B., Fischl B. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 2006, 32:180-194.
23. Harley M., Kelleher I., Clarke M., Lynch F., Arseneault L., Connor D., Fitzpatrick C., Cannon M. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychological Medicine 2010, 40:1627-1634.
24. Haselgrove J.C., Moore J.R. Correction for distortion of echo-planar images used to calculate the apparent diffusion coefficient. Magnetic Resonance in Medicine 1996, 36:960-964.
25. Hollingshead A.B., Redlich F.C. Social class and mental illness: a community study. 1958. American Journal of Public Health 2007, 97:1756-1757.
26. Jacobson S., Kelleher I., Harley M., Murtagh A., Clarke M., Blanchard M., Connolly C., O[U+05F3]Hanlon E., Garavan H., Cannon M. Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren. NeuroImage 2010, 49:1875-1885.
27. Jacobus J., McQueeny T., Bava S., Schweinsburg B.C., Frank L.R., Yang T.T., Tapert S.F. White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicology and Teratology 2009, 31:349-355.
28. James A.C., James S., Smith D.M., Javaloyes A. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. American Journal of Psychiatry 2004, 161:1023-1029.
29. Jones D.K., Knosche T.R., Turner R. White matter integrity, fiber count, and other fallacies: the do[U+05F3]s and don[U+05F3]ts of diffusion MRI. NeuroImage 2013, 73:239-254.
30. Kikinis Z., Makris N., Finn C.T., Bouix S., Lucia D., Coleman M.J., Tworog-Dube E., Kikinis R., Kucherlapati R., Shenton M.E., Kubicki M. Genetic contributions to changes of fiber tracts of ventral visual stream in 22q11.2 deletion syndrome. Brain Imaging and Behavior 2013, 7:316-325.
31. Kumra S. Schizophrenia and cannabis use. Minnesota Medicine 2007, 90:36-38.
32. Kumra S., Robinson P., Tambyraja R., Jensen D., Schimunek C., Houri A., Reis T., Lim K. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51:171-180.
33. Lebel C., Beaulieu C. Longitudinal development of human brain wiring continues from childhood into adulthood. Journal of Neuroscience 2011, 31:10937-10947.
34. Loy J.H., Merry S.N., Hetrick S.E., Stasiak K. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Systematic Reviews 2012, 9:CD008559.
35. Lynskey M., Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000, 95:1621-1630.
36. McQueeny T., Schweinsburg B.C., Schweinsburg A.D., Jacobus J., Bava S., Frank L.R., Tapert S.F. Altered white matter integrity in adolescent binge drinkers. Alcoholism, Clinical and Experimental Research 2009, 33:1278-1285.
37. Moldrich G., Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 2000, 21:1735-1742.
38. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
39. Palaniyappan L., Al-Radaideh A., Mougin O., Gowland P., Liddle P.F. Combined white matter imaging suggests myelination defects in visual processing regions in schizophrenia. Neuropsychopharmacology 2013, 38:1808-1815.
40. Pope H.G., Gruber A.J., Hudson J.I., Cohane G., Huestis M.A., Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug and Alcohol Dependence 2003, 69:303-310.
41. Rodriguez-Sanchez J.M., Ayesa-Arriola R., Mata I., Moreno-Calle T., Perez-Iglesias R., Gonzalez-Blanch C., Perianez J.A., Vazquez-Barquero J.L., Crespo-Facorro B. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia Research 2010, 124:142-151.
42. Rodriguez J.J., Mackie K., Pickel V.M. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. Journal of Neuroscience 2001, 21:823-833.
43. Sanchez C., Galve-Roperh I., Canova C., Brachet P., Guzman M. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Letters 1998, 436:6-10.
44. Scholz J., Klein M.C., Behrens T.E., Johansen-Berg H. Training induces changes in white-matter architecture. Nature Neuroscience 2009, 12:1370-1371.
45. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23(Suppl 1):S208-S219.
46. Sobell L.C., Sobell M.B. Timeline followback: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, Totowa, NJ. R.Z. Litten, J. Allen (Eds.).
47. Szeszko P.R., Robinson D.G., Ikuta T., Peters B.D., Gallego J.A., Kane J., Malhotra A.K. White matter changes associated with antipsychotic treatment in first-episode psychosis. Neuropsychopharmacology 2014, 39:1324-1331.
48. Tamnes C.K., Ostby Y., Fjell A.M., Westlye L.T., Due-Tonnessen P., Walhovd K.B. Brain maturation in adolescence and young adulthood: regional age-related changes in cortical thickness and white matter volume and microstructure. Cerebral Cortex 2010, 20:534-548.
49. van Os J., Kenis G., Rutten B.P. The environment and schizophrenia. Nature 2010, 468:203-212.
50. Waksman Y., Olson J.M., Carlisle S.J., Cabral G.A. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. Journal of Pharmacology and Experimental Therapeutics 1999, 288:1357-1366.
51. Walhovd K.B., Moe V., Slinning K., Due-Tonnessen P., Bjornerud A., Dale A.M., van der Kouwe A., Quinn B.T., Kosofsky B., Greve D., Fischl B. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. NeuroImage 2007, 36:1331-1344.
52. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. Journal of Neuroscience 2003, 23:1398-1405.
53. Wilkinson G. Wide Range Achievement Test (WRAT-3) Manual 1993, Wide Range, Inc., Wilmington, DE. 3rd Edition.
54. Yao L., Lui S., Liao Y., Du M.Y., Hu N., Thomas J.A., Gong Q.Y. White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013, 45C:100-106.
55. Zalesky A., Solowij N., Yucel M., Lubman D.I., Takagi M., Harding I.H., Lorenzetti V., Wang R., Searle K., Pantelis C., Seal M. Effect of long-term cannabis use on axonal fibre connectivity. Brain 2012, 135:2245-2255.